Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
This grant funds research to identify and evaluate methods for addressing nitrosamine impurities in pharmaceutical drugs.
About this program
The grant focuses on the identification and evaluation of potential approaches to mitigate nitrosamine impurities found in drugs. Nitrosamines are a class of compounds that can pose significant health risks, and their presence in pharmaceuticals has raised concerns among regulatory agencies. This funding aims to support research initiatives that explore innovative solutions to this pressing issue, ensuring the safety and efficacy of drug products. Researchers, pharmaceutical companies, and academic institutions are encouraged to apply for this grant to contribute to the development of safer medications.
Eligibility
Eligible applicants include academic institutions, research organizations, and pharmaceutical companies engaged in drug development and safety research.
Requirements
- Submit a detailed research proposal
- Demonstrate expertise in pharmaceutical sciences